🇺🇸 FDA
Patent

US 6673780

Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses

expired A61PA61P1/18A61P13/12

Quick answer

US patent 6673780 (Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/18, A61P13/12, A61P15/10, A61P25/28